Developer of a liquid biopsy platform designed to obtain rare circulating tumor cells from the patient's blood. The company's platform uses disposable microfluidic chip technology to isolate white blood cells for further analysis and also removing red blood cells and platelets to undetectable levels, thereby replacing current manual processing of leukapheresis samples with a robust, high-precision, automatable, closed system, enabling medical scientists to separate cells that pumps blood through a disposable microchip, while cutting the costs of cell therapies.